Why the study?
Does ivabradine improve myocardial electrophysiology and reduce arrhythmias in patients with atrial fibrillation or structural heart disease?
Does ivabradine improve myocardial electrophysiology and reduce arrhythmias in patients with atrial fibrillation or structural heart disease?
Answers are grounded in this paper and cite their sources.
Ivabradine may have potential off-label benefits for rate control in atrial fibrillation and suppression of ventricular arrhythmias in structural heart disease.
The article is focused on the data concerning the influence of ivabradine on myocardial electrophysiology in experimental and clinical studies. It is shown that ivabradine decreases ventricular rate in chronic atrial fibrillation, and prevents the paroxysms of atrial fibrillation. In myocardial hypertrophy patients or in serious chamber dilation, ivabradine shows moderate antiarrhythmic effect on ventricular arrhythmias.
No takes yet. Share an insight, caveat, or question.
E. I. Tarlovskaya (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: